NVCR NovoCure Limited

$15.51▲ +1.04% Healthcare Other
After hours $15.51▲ +0.00% Sep 11, 7:30 PM ET
Volume 1.13M Avg Volume (10D) 984.4K
Key Metrics & Fundamentals
Market Cap
$1.81B
P/E Ratio
–
Div Yield
–%
52W Range
9.82 - 21.45
% vs 50 MA
-7.82%
% vs 200 MA
7.42%
RSI-14
39.2
MACD Histogram
-0.3000
Beta (1Y vs SPY)
1.61
Free Cash Flow
$1.22M
Gross Rev
$183.58M
Gross Profit
$142.48M
EBITDA
-$6.26M
COGS
$41.11M
Operating Exp
$153.04M
Operating Income
-$10.56M
EBIT
-$10.56M
Pretax Income
-$12.45M
Net Income
-$15.66M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Novocure Reports Patient Data Exposure in Cybersecurity Incident
Zacks · Sep 7, 2026 3:12 PM
Novocure Announces Upcoming Investor Events
Business Wire · Sep 2, 2026 11:00 AM
Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High?
Zacks · Aug 28, 2026 1:55 PM
Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice
Zacks · Aug 20, 2026 4:00 PM
Which Medtech Giant Would Buy Inspire Medical Systems?
Trefis · Aug 14, 2026 9:54 PM
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet
Zacks · Aug 12, 2026 1:55 PM
4 Healthcare Stocks to Watch as Defensive Demand Strengthens
Zacks · Aug 7, 2026 12:59 PM
NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Jul 27, 2026 4:00 PM
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade
Zacks · Jul 27, 2026 1:55 PM
Unlocking NovoCure (NVCR) International Revenues: Trends, Surprises, and Prospects
Zacks · Jul 27, 2026 1:15 PM
Financial Overview - Income Statement Quarterly

See NVCR's money flow as a full page

Social Sentiment
Avg +0.68 · 5 posts
This is a Wow. Pancreatic cancer used to be a brutal death sentence
r/stocks · Feb 12, 2026
The post expresses excitement about the FDA approval and suggests the company's market cap is undervalued, indicating a bullish sentiment.
positive +0.60
NewsTradeNovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
r/wallstreetbets · Dec 2, 2024
Significant positive trial data and stock price movement discussed.
very_positive +1.00
NewsTradeDDThese are the stocks on my watchlist (12/2)
r/StockMarket · Dec 2, 2024
Mentioned as having a potentially higher fair value based on an analysis.
positive +0.40
NewsDiscussionTradeWill $NVCR have a rebound?
r/wallstreetbets · Nov 25, 2024
The post shows cautious optimism due to recent FDA approval, trial successes, and new leadership, though previous drops are acknowledged.
positive +0.60
NewsDiscussionTrade$NVCR Bullish PANOVA-3 Trial
r/wallstreetbets · Sep 4, 2024
The post is highly optimistic about NVCR's PANOVA-3 trial results and their potential impact.
very_positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙